May 13, 2019 / 9:40 PM / 4 months ago

BRIEF-Homology Medicines Reports Q1 Loss Per Share $0.64

May 13 (Reuters) - Homology Medicines Inc:

* HOMOLOGY MEDICINES REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS AND RECENT HIGHLIGHTS

* Q1 LOSS PER SHARE $0.64

* Q1 EARNINGS PER SHARE ESTIMATE $-0.53 -- REFINITIV IBES DATA

* AS OF MARCH 31, 2019, HOMOLOGY HAD APPROXIMATELY $188.0 MILLION IN CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

* EXPECTS ITS CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS WILL ALLOW COMPANY TO CONTINUE ITS OPERATIONS INTO Q4 OF 2021

* COLLABORATION REVENUE FOR QUARTER ENDED MARCH 31, 2019 WAS $0.3 MILLION, COMPARED TO $1.1 MILLION FOR QUARTER ENDED MARCH 31, 2018

* CO AND NOVARTIS CONTINUE TO WORK TOGETHER ON TWO OPHTHALMIC PROGRAMS AND SEEK TO IDENTIFY NEW TARGETS FOR PARTNERSHIP Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below